Possible role for interactions between 5-lipoxygenase (5-LOX) and AMPA GluR1 receptors in depression and in antidepressant therapy

Medical Hypotheses

Volumn 69, Issue 5, 2007, Pages 1076-1079

  Manev, Radmila ^a   Mrazovac, Danijela ^a   Manev, Hari ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; ANTIDEPRESSANT AGENT; ARACHIDONATE 5 LIPOXYGENASE; GLUTAMATE RECEPTOR 1;

ARTICLE; DEPRESSION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANTIDEPRESSIVE AGENTS; ARACHIDONATE 5-LIPOXYGENASE; BRAIN; DEPRESSION; HUMANS; MODELS, NEUROLOGICAL; RECEPTORS, AMPA; SIGNAL TRANSDUCTION;

EID: 34548725481     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.02.038     Document Type: Article

References (27)

1. Stewart J.C., Janicki D.L., Muldoon M.F., Sutton-Tyrrell K., and Kamarck T.W. Negative emotions and 3-year progression of subclinical atherosclerosis. Arch Gen Psychiat 64 (2007) 225-333
2. Manev R., and Manev H. 5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders. Crit Rev Neurobiol 16 (2004) 181-186
3. Mehrabian M., and Allayee H. 5-Lipoxygenase and atherosclerosis. Curr Opin Lipidol 14 (2003) 447-457
4. Manev H., and Uz T. The possible roles of lipoxygenase metabolism in psychiatric and neurological disorders. In: Peet M., Glen I., and Horrobin D.F. (Eds). Phospholipid spectrum disorders (2003), Marius Press, Lancashire, UK
5. Chinnici C.M., Yao Y., and Pratico D. The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. Neurobiol Aging (2006) [Epub ahead of print]
6. Roche K.W., Tingley W.G., and Huganir R.L. Glutamate receptor phosphorylation and synaptic plasticity. Curr Opin Neurobiol 4 (1994) 383-388
7. Derkach V.A., Oh M.C., Guire E.S., and Soderling T.R. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 8 (2007) 101-113
8. Lee H.K., Takamiya K., Han J.S., Man H., Kim C.H., Rumbaugh G., et al. Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112 (2003) 631-643
9. Palmer C.L., Cotton L., and Henley J.M. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev 57 (2005) 253-277
10. Coyle J.T. The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiat 3 (1996) 241-253
11. Li X., Witkin J.M., Need A.B., and Skolnick P. Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell Mol Neurobiol 23 (2003) 419-430
12. Sequeira A., and Turecki G. Genome wide gene expression studies in mood disorders. OMICS 10 (2006) 444-454
13. Beneyto M., Kristiansen L.V., Oni-Orisan A., McCullumsmith R.E., and Meador-Woodruff J.H. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology (2007) [Epub ahead of print]
14. Svenningsson P., Tzavara E.T., Witkin J.M., Fienberg A.A., Nomikos G.G., and Greengard P. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc Natl Acad Sci USA 99 (2002) 3182-3187
15. Martinez-Turrillas R., Frechilla D., and Del Rio J. Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus. Neuropharmacology 43 (2002) 1230-1237
16. Du J., Suzuki K., Wei Y., Wang Y., Blumenthal R., Chen Z., et al. The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology (2006) [Epub ahead of print]
17. Martinez-Turrillas R., Del Rio J., and Frechilla D. Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment. Neuropharmacology 49 (2005) 1178-1188
18. Martinez-Turrillas R., Del Rio J., and Frechilla D. Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs. Biochem Biophys Res Commun 353 (2007) 750-755
19. Tan C.H., He X., Yang J., and Ong W.Y. Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline: a link between noradrenergic and glutamatergic function?. Exp Brain Res 170 (2006) 448-456
20. Menard C., Valastro B., Martel M.A., Chartier E., Marineau A., Baudry M., et al. AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities. Hippocampus 15 (2005) 370-380
21. Imbesi M, Zavoreo I, Uz T, Sharma RP, Dimitrijevic N, Manev H, Manev R. 5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in-vitro and in the mouse cortex in-vivo. Brain Res 2007 [Epub ahead of print].
22. Chabot C., Gagne J., Giguere C., Bernard J., Baudry M., and Massicotte G. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Hippocampus 8 (1998) 299-309
23. Holderbach R., Clark K., Moreau J.L., Bischofberger J., and Normann C. Enhanced long-term synaptic depression in an animal model of depression. Biol Psychiat (2006) [Epub ahead of print]
24. Du L., Zhang Z., Luo X., Chen K., Shen X., and Jiang H. Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation. J Biochem (Tokyo) 139 (2006) 715-723
25. Takeda H., Tsuji M., Yamada T., Masuya J., Matsushita K., Tahara M., et al. Caffeic acid attenuates the decrease in cortical BDNF mRNA expression induced by exposure to forced swimming stress in mice. Eur J Pharmacol 534 (2006) 115-121
26. Uz T., Dwivedi Y., Savani P.D., Impagnatiello F., Pandey G., and Manev H. Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain. J Neurochem 73 (1999) 693-699
27. Uz T., Dwivedi Y., Qeli A., Peters-Golden M., Pandey G., and Manev H. Glucocorticoid receptors are required for up-regulation of neuronal 5-lipoxygenase (5LOX) expression by dexamethasone. FASEB J 15 (2001) 1792-1794